Investigating cancer treatment effects during pregnancy on mothers and children
Official title: Oncological Treatment During Pregnancy: Pharmacokinetics of Chemotherapy and Long Term Follow up of the Offspring
Run by University Hospital, Gasthuisberg · NCT00330447 · Data updated 2026-11-12
This study looks at how cancer treatments during pregnancy affect mothers and their children in the long run.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 5000 (estimated) |
| Sponsor | University Hospital, Gasthuisberg Academic / other |
| Drugs / interventions | radiation, chemotherapy |
| Locations | 33 sites (Camden, New Jersey and 32 other locations) |
| Status | Recruiting |
| Started | August 2005 |
| Main results expected | April 2025 |
| Study ends | December 2032 |
| Registry record updated | March 6, 2024 |
| Trial ID | NCT00330447 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include premenopausal women over 18 years old with histologically proven cancer diagnosed during pregnancy or within five years post-pregnancy.
✕Probably not a fit
Patients with significant mental disabilities that prevent informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the outcomes for mothers diagnosed with cancer during pregnancy and the long-term effects on their children who were exposed to cancer treatments such as chemotherapy and radiotherapy. It includes collecting maternal blood samples, umbilical cord blood, and biopsies to evaluate fetal growth and maternal health. Additionally, the study will measure maternal and paternal anxiety related to the cancer diagnosis and conduct long-term follow-ups on the children to monitor their neurological and cardiological development. The study is structured in two parts, focusing on both maternal outcomes and child development.
Why it matters
Potential benefit: If successful, this study could provide critical insights into the safety and outcomes of cancer treatments during pregnancy, potentially guiding future clinical practices.
How similar studies have gone: While there have been studies on cancer treatment during pregnancy, this specific approach focusing on long-term outcomes for both mothers and children is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patients do not need to participate in both; however, preferentially both study parts should be performed. \*\*\*\*\*\*\*\*\*\*\*\*\*\*Part I: Pregnancy, delivery and maternal health\*\*\*\*\*\*\*\*\*\*\*\*\*\* Patients must meet the following inclusion criteria: * Histologically proven cancer in association with a pregnancy (during pregnancy or cancer dagnosis within 5 years after pregnancy) * \> 18 years of age, premenopausal * Patients who have given their signed and written informed consent to participate in the trial after fully understanding the implication of the protocol * Women receiving any cytotoxic drug or radiation therapy during pregnancy are allowed for the assessment of the maternal and fetal outcome (Part II). Exclusion Criteria: * Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent \*\*\*\*\*\*\*\*\*\*\*\*\*\*Part II: Follow-up of children\*\*\*\*\*\*\*\*\*\*\*\*\*\* Inclusion Criteria: \- Children that were prenatally exposed to cancer of cancer treament. Informed Consent is asked from parents. From the age of 12 years, informed assent is additionally asked from the child. After the age of 18 years, informed consent is solely asked of the offspring. Exclusion Criteria: * Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent
Where it's running
-
Cooper University Hospital (2015-ongoing)
Camden, New Jersey, United States Recruiting -
UCL Brussels (2013-ongoing)
Brussels, Belgium Recruiting -
UZ Gasthuisberg, Katholieke Universiteit Leuven (2004-ongoing)
Leuven, Belgium Recruiting -
University Hospital Ostrava (2018-ongoing)
Ostrava, Czechia Recruiting -
3rd medical faculty of Charles University (2010-ongoing)
Prague, Czechia Recruiting -
Copenhagen University Hospital (2015-ongoing)
Copenhagen, Denmark Recruiting
Show 27 more locations
-
Euroclinic Hospital (2016-ongoing)
Athens, Greece Recruiting -
European Institute of Oncology (2010-ongoing)
Milan, Italy Recruiting -
Fondazione IRCCS Ca'Granda Ospedale Maggiore (2012-ongoing)
Milan, Italy Recruiting -
Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico Milano (2017-ongoing)
Milan, Italy Recruiting -
San Raffaele Hospital (2017-ongoing)
Milan, Italy Recruiting -
CIttà della Salute e della Scienza di Torino (2015-ongoing)
Torino, Italy Recruiting -
Regional Hospital of High Specialty of Ixtapaluca (2018-ongoing)
Ixtapaluca, Mexico Recruiting -
Erasmus Medical Center (2014-ongoing)
Rotterdam, Netherlands Recruiting -
Haukeland University Hospital (2017-ongoing)
Bergen, Norway Recruiting -
University Hospital Krakow (2018-ongoing)
Krakow, Poland Recruiting -
Pozanan University of Medical Sciences (2017-ongoing)
Poznan, Poland Recruiting -
Hospital de Vila Franca de Xira (2017-ongoing)
Vila Franca de Xira, Portugal Recruiting -
N.N.Blokchin National Medical Research Center of Oncology (2013-2018 retrospective; 2018-ongoing prospective)
Moscow, Russia Recruiting -
Research Center for Obstetrics, Gynecology and Perinatology (2014-ongoing)
Moscow, Russia Recruiting -
Almazov National Medical Research Center (2018-ongoing)
Saint Petersburg, Russia Recruiting -
Karolinska University Hospital (2017-ongoing)
Stockholm, Sweden Recruiting -
Instituto Alexander Fleming
Buenos Aires, Argentina Withdrawn -
Universitätsklinik für Frauenheilkunde und Geburtshilfe (retrospective 2016-2018)
Graz, Austria Terminated -
Hopital Bichat-Claude-Bernard (retrospective until 2018)
Paris, France Terminated -
Universitätsklinik Freiburg (retrospective until 2018)
Freiburg im Breisgau, Germany Terminated -
Hellenic Anticancer-Oncological Hospital of Athens (retrospective 2015-2018)
Athens, Greece Terminated -
Ioannina University Hospital (retrosepctive 2015-2018)
Ioannina, Greece Terminated -
Hippokration Hospital (retrospective 2015-2018)
Thessaloniki, Greece Terminated -
Medyczne Macierzynstwo (retrospective 2010-2018)
Krakow, Poland Terminated -
F.Hached University Teaching Hospital (retrospective 2016-2018)
Sousse, Tunisia Terminated -
Trakya University Faculty of Medicine (retrospective 2015-2018)
Edirne, Turkey (Türkiye) Terminated -
Grigoriev Institute for medical Radiology (retrospective until 2018)
Kharkiv, Ukraine Terminated
Study contacts
- Principal investigator: Amant Frederic, MD PhD — KULeuven, Belgium
- Study coordinator: Ayaka Wakatsuki
- Email: ayaka.wakatsuki@uzleuven.be
- Phone: +32 16 34 41 69
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
-
Pregnant women weight-management support via an app and care model
Aims to try a smartphone-based weight-management program plus professional support for pregnant women to see if it helps manage gestational weight and promote healthy behaviors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.